Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ·Healthcare·Biotechnology
$10.63
+1.72%
Mkt Cap $1.86B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (10 analysts)
$15.00
Range $14.00 – $16.00
Implied Upside
+41.2%
Consensus $15.00 vs current $10.63
NASDAQ·Healthcare·Biotechnology
$10.63
+1.72%
Mkt Cap $1.86B
Buy
3
Hold
0
Sell
0
Price Target (10 analysts)
$15.00
Range $14.00 – $16.00
+41.2%
Consensus $15.00 vs current $10.63